207 related articles for article (PubMed ID: 15813835)
21. Pancreatic enzyme therapy for pancreatic exocrine insufficiency.
Domínguez-Muñoz JE
Curr Gastroenterol Rep; 2007 Apr; 9(2):116-22. PubMed ID: 17418056
[TBL] [Abstract][Full Text] [Related]
22. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
[TBL] [Abstract][Full Text] [Related]
23. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin.
Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD
Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of a 13C-labeled mixed triglyceride breath test for assessing pancreatic exocrine function after pancreatic surgery.
Nakamura H; Morifuji M; Murakami Y; Uemura K; Ohge H; Hayashidani Y; Sudo T; Sueda T
Surgery; 2009 Feb; 145(2):168-75. PubMed ID: 19167971
[TBL] [Abstract][Full Text] [Related]
25. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
[TBL] [Abstract][Full Text] [Related]
26. Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts.
Graham DY
N Engl J Med; 1977 Jun; 296(23):1314-7. PubMed ID: 16212
[TBL] [Abstract][Full Text] [Related]
27. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
Whitcomb DC; Lehman GA; Vasileva G; Malecka-Panas E; Gubergrits N; Shen Y; Sander-Struckmeier S; Caras S
Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447
[TBL] [Abstract][Full Text] [Related]
28. Management of chronic pancreatitis. Focus on enzyme replacement therapy.
Dobrilla G
Int J Pancreatol; 1989; 5 Suppl():17-29. PubMed ID: 2702247
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic exocrine insufficiency: diagnosis and treatment.
Domínguez-Muñoz JE
J Gastroenterol Hepatol; 2011 Mar; 26 Suppl 2():12-6. PubMed ID: 21323992
[TBL] [Abstract][Full Text] [Related]
30. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
Lankisch PG; Lembcke B; Göke B; Creutzfeldt W
Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109
[TBL] [Abstract][Full Text] [Related]
31. Management of maldigestion associated with pancreatic insufficiency.
Perry RS; Gallagher J
Clin Pharm; 1985; 4(2):161-9. PubMed ID: 3987214
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic enzyme supplement improves dysmotility in chronic pancreatitis patients.
Mizushima T; Ochi K; Ichimura M; Kiura K; Harada H; Koide N
J Gastroenterol Hepatol; 2004 Sep; 19(9):1005-9. PubMed ID: 15304117
[TBL] [Abstract][Full Text] [Related]
33. [Comparative clinical study of Neopanpur and Creon].
Beró T; Jávor T
Orv Hetil; 1994 Jan; 135(1):7-14. PubMed ID: 8290236
[TBL] [Abstract][Full Text] [Related]
34. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
Lankisch PG; Lembcke B; Kirchhoff S; Hilgers R; Creutzfeldt W
Dtsch Med Wochenschr; 1988 Jan; 113(1):15-7. PubMed ID: 3335192
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
[TBL] [Abstract][Full Text] [Related]
36. [Stimulation of immunoglobulin E formation in chronic pancreatitis by alcohol drinking and exocrine pancreatic insufficiency].
Raithel M; Dormann H; Farnbacher M; Weidenhiller M; Hahn EG; Schneider HT
Z Gastroenterol; 2001 Apr; 39(4):269-76. PubMed ID: 11367975
[TBL] [Abstract][Full Text] [Related]
37. Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts.
Domínguez-Muñoz JE; Iglesias-García J; Iglesias-Rey M; Vilariño-Insua M
Gut; 2006 Jul; 55(7):1056-7. PubMed ID: 16766768
[No Abstract] [Full Text] [Related]
38. [Exocrine pancreatic insufficiency. Comparison of substitution therapy with a non-acid resistant and an acid resistant enzyme preparation].
Freise J; Horstkotte H
Fortschr Med; 1986 Sep; 104(33):625-8. PubMed ID: 3639835
[No Abstract] [Full Text] [Related]
39. New modalities in the treatment of exocrine pancreatic insufficiency in cystic fibrosis.
Heijerman HG
Neth J Med; 1992 Oct; 41(3-4):105-9. PubMed ID: 1470278
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and treatment of pancreatic exocrine insufficiency.
Lindkvist B
World J Gastroenterol; 2013 Nov; 19(42):7258-66. PubMed ID: 24259956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
